ACTIVITY IN THE THIRD QUARTER OF 2018
(Unaudited data)
- CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2018
| in thousands of euros | 2017 | 2018 | Variation at current exchange rates | Variation at constant exchange rates |
| France | 277,885 | 263,408 | -5.2% | -5.2% |
| Europe (excluding France) | 110,158 | 95,664 | -13.2% | -11.1% |
| North America | 48,699 | 63,260 | +29.9% | +39.0% |
| Other countries | 11,849 | 14,042 | +18.5% | +25.0% |
| Group total | 448,591 | 436,374 | -2.7% | -1.1% |
| in thousands of euros | 2017 | 2018 | Variation at current exchange rates | Variation at constant exchange rates |
| Non-proprietary Homeopathic Medicines | 229,933 | 213,065 | -7.3% | -7.0% |
| OTC Specialties | 217,701 | 222,394 | +2.2% | +5.2% |
| Other | 957 | 915 | -4.4% | -4.3% |
| Group total | 448,591 | 436,374 | -2.7% | -1.1% |
- DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)
| in thousands of euros | 1st quarter | 2nd quarter | 3rd quarter | ||||||
| 2017 | 2018 | Var. 18/17 | 2017 | 2018 | Var. 18/17 | 2017 | 2018 | Var. 18/17 | |
| France | 97,134 | 91,982 | -5.3% | 79,328 | 77,199 | -2.7% | 101,423 | 94,227 | -7.1% |
| Europe (excluding France) | 40,418 | 32,899 | -18.6% | 27,421 | 24,795 | -9.6% | 42,319 | 37,970 | -10.3% |
| North America | 18,179 | 29,617 | +62.9% | 14,465 | 14,958 | +3.4% | 16,055 | 18,685 | +16.4% |
| Other countries | 4,532 | 4,895 | +8.0% | 3,191 | 4,185 | +31.2% | 4,126 | 4,962 | +20.3% |
| Group total | 160,263 | 159,393 | -0.5% | 124,405 | 121,137 | -2.6% | 163,923 | 155,844 | -4.9% |
| in thousands of euros | 1st quarter | 2nd quarter | 3rd quarter | ||||||
| 2017 | 2018 | Var. 18/17 | 2017 | 2018 | Var. 18/17 | 2017 | 2018 | Var. 18/17 | |
| Non-proprietary Homeopathic Medicines | 81,016 | 76,575 | -5.5% | 74,567 | 69,997 | -6.1% | 74,350 | 66,493 | -10.6% |
| OTC Specialties | 78,968 | 82,506 | +4.5% | 49,391 | 50,791 | +2.8% | 89,342 | 89,097 | -0.3% |
| Other | 279 | 312 | +11.8% | 447 | 349 | -21.9% | 231 | 254 | +10.0% |
| Group total | 160,263 | 159,393 | -0.5% | 124,405 | 121,137 | -2.6% | 163,923 | 155,844 | -4.9% |
- HIGHLIGHTS OF THE THIRD QUARTER
Sales in the third quarter of 2018 are down by 4.9% in comparison to 2017 (-4.4% at constant exchange rates).
This decrease comes mainly from France and Italy. On the contrary, sales are growing in the USA.
- OUTLOOK
For 2018, the operating income should be down compared to 2017.
We carry on the development of homeopathy in the world with the same confidence and the same determination.
Laboratoires BOIRON
Our next update:
January 24, 2019: at market close, publication of the sales revenue for the year 2018.
Person responsible for financial information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail: boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information and the glossary are online at: www.boironfinance.com
https://www.actusnews.com/documents_communiques/ACTUS-0-55595-boi-181018-ca-t3-18-gb.pdf
© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
